Richard Newitter
Stock Analyst at Truist Securities
(4.28)
# 420
Out of 4,911 analysts
373
Total ratings
53.12%
Success rate
14.66%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Hold | $81 → $82 | $80.17 | +2.28% | 19 | Jul 25, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $120 → $125 | $106.35 | +17.54% | 17 | Jul 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $590 → $600 | $494.53 | +21.33% | 29 | Jul 23, 2025 | |
| TNDM Tandem Diabetes Care | Initiates: Hold | $24 | $15.53 | +54.54% | 1 | Jun 16, 2025 | |
| DXCM DexCom | Initiates: Buy | $102 | $88.23 | +15.61% | 1 | Jun 16, 2025 | |
| PODD Insulet | Initiates: Buy | $365 | $290.74 | +25.54% | 1 | Jun 16, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $26 | $14.31 | +81.69% | 1 | Jun 16, 2025 | |
| GMED Globus Medical | Maintains: Hold | $80 → $68 | $53.92 | +26.11% | 27 | May 12, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $127 → $117 | $71.25 | +64.21% | 18 | May 8, 2025 | |
| TFX Teleflex | Maintains: Hold | $140 → $137 | $116.00 | +18.10% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $390 → $400 | $399.71 | +0.07% | 20 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $140 → $135 | $94.28 | +43.19% | 5 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $150 | $106.30 | +41.11% | 7 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $70 | $54.29 | +28.94% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $51 | $40.10 | +27.18% | 3 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9.5 → $8 | $5.66 | +41.34% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $90 | $92.43 | -2.63% | 15 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $22.65 | +5.98% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $12.67 | +49.96% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $132.90 | +9.10% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $235 | $128.19 | +83.32% | 24 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $96.65 | +16.92% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $230.35 | +23.72% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $17.27 | +21.60% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $7.76 | +157.73% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $91.27 | -10.16% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $184.13 | +35.77% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $4.74 | +449.10% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $202.80 | +279.68% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $66.30 | +28.21% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.98 | +54.14% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $13.19 | +104.70% | 5 | Feb 23, 2021 |
Edwards Lifesciences
Jul 25, 2025
Maintains: Hold
Price Target: $81 → $82
Current: $80.17
Upside: +2.28%
Boston Scientific
Jul 24, 2025
Maintains: Buy
Price Target: $120 → $125
Current: $106.35
Upside: +17.54%
Intuitive Surgical
Jul 23, 2025
Maintains: Buy
Price Target: $590 → $600
Current: $494.53
Upside: +21.33%
Tandem Diabetes Care
Jun 16, 2025
Initiates: Hold
Price Target: $24
Current: $15.53
Upside: +54.54%
DexCom
Jun 16, 2025
Initiates: Buy
Price Target: $102
Current: $88.23
Upside: +15.61%
Insulet
Jun 16, 2025
Initiates: Buy
Price Target: $365
Current: $290.74
Upside: +25.54%
Beta Bionics
Jun 16, 2025
Initiates: Buy
Price Target: $26
Current: $14.31
Upside: +81.69%
Globus Medical
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $53.92
Upside: +26.11%
Lantheus Holdings
May 8, 2025
Maintains: Buy
Price Target: $127 → $117
Current: $71.25
Upside: +64.21%
Teleflex
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $116.00
Upside: +18.10%
May 5, 2025
Maintains: Hold
Price Target: $390 → $400
Current: $399.71
Upside: +0.07%
May 1, 2025
Reiterates: Buy
Price Target: $140 → $135
Current: $94.28
Upside: +43.19%
Apr 28, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $106.30
Upside: +41.11%
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $54.29
Upside: +28.94%
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $40.10
Upside: +27.18%
Apr 11, 2025
Maintains: Hold
Price Target: $9.5 → $8
Current: $5.66
Upside: +41.34%
Apr 11, 2025
Maintains: Hold
Price Target: $93 → $90
Current: $92.43
Upside: -2.63%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $22.65
Upside: +5.98%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $12.67
Upside: +49.96%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $132.90
Upside: +9.10%
Feb 11, 2025
Maintains: Buy
Price Target: $250 → $235
Current: $128.19
Upside: +83.32%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $96.65
Upside: +16.92%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $230.35
Upside: +23.72%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $17.27
Upside: +21.60%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $7.76
Upside: +157.73%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $91.27
Upside: -10.16%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $184.13
Upside: +35.77%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $4.74
Upside: +449.10%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $202.80
Upside: +279.68%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $66.30
Upside: +28.21%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.98
Upside: +54.14%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $13.19
Upside: +104.70%